Parallel Advisors’s Medicines Co MDCO Stock Holding History

Parallel Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-56	Closed	-$5K	–	2796
2019 Q4	$5K	Hold	56	–	–	﹤0.01%	1994
2019 Q3	$3K	Hold	56	–	–	﹤0.01%	2124
2019 Q2	$2K	Hold	56	–	–	﹤0.01%	2159
2019 Q1	$2K	Buy	+56	New	+$1.32K	﹤0.01%	2144
2017 Q3	–	Sell	-5	Closed	–	–	2294
2017 Q2	$0	Sell	5 -12	-71%	-$534	﹤0.01%	2264
2017 Q1	$1K	Buy	+17	New	+$775	﹤0.01%	1957

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Parallel Advisors's MDCO Position: Q1 2020 in Review

Parallel Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 56 shares — an estimated $5K sold.

Parallel Advisors first reported a position in MDCO in Q1 2017 and held it in 6 quarters. The position peaked at $5K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Parallel Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Parallel Advisors sold 56 Medicines Co shares in Q1 2020, an estimated $5K.
Parallel Advisors first reported a position in Medicines Co in Q1 2017 and held it in 6 quarters.
Parallel Advisors's Medicines Co position peaked at $5K in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.